Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.

Virchows Archiv : an international journal of pathology - 1 Oct 2024

Fairley Jennifer A, Badrick Tony, Denis Marc G, Dimitrova Lora, Goodall Rebecca, Maas Joerg, Normanno Nicola, Patton Simon J, Rouleau Etienne, Russo Antonio, Stockley Tracy L, Deans Zandra C

Abstract excerpt

Demand for large-scale tumour profiling across cancer types has increased in recent years, driven by the emergence of targeted drug therapies. Analysing alternations in plasma circulating tumour DNA (ctDNA) for cancer detection can improve survival; ctDNA testing is recommended when tumour tissue is unavailable. An online survey of molecular pathology testing was circulated by six external quality assessment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to High-Throughput Nucleotide Sequencing

Share to Liquid Biopsy

Share to Neoplasms

Share to Pathology, Molecular

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 37202567
DOI: 10.1007/s00428-023-03558-x
PMCID: PMC11522039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.PMID 37202567Read ↗

Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumorsSemantic proximity Read ↗

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA.Semantic proximity Read ↗

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.Semantic proximity Read ↗

Noninvasive MRD monitoring and profiling of clonal evolution by ctDNA in patients with advanced cancers treated within molecular tumor boardsSemantic proximity Read ↗

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.Semantic proximity Read ↗

Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test.Semantic proximity Read ↗

Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and StagesSemantic proximity Read ↗

Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Semantic proximity Read ↗

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.Semantic proximity Read ↗

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read ↗

Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors.Semantic proximity Read ↗

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.